Market OverviewThe Global Breast Cancer Therapeutics Market remains one of the most prevalent forms of cancer worldwide, ...
Ado-trastuzumab emtansine led to improved overall survival and invasive disease–free survival over trastuzumab in patients ...
SINGAPORE, Feb. 11, 2025 /PRNewswire/ -- A NEW breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-free survival in women is now approved for use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback